For years scientists have been searching for a successful vaccine against the malaria parasite. Thousands of children and adults suffer from malaria worldwide and while there are medicines to treat the disease and reduce the affects no one has been able to come up with an effective vaccine. Fortunately that may have all changed; a group of researchers released test data this week that shows that their trial malaria vaccine may actually be successful.
The vaccine for malaria has been in development by GlaxoSmithKline for over 25 years and now that the team of researchers has done their first real world trial the results are promising. According to the study nearly half of all children given the vaccine were protected from serious attacks from malaria. This may seem like an ineffective vaccine but up until this point no trial medication has been nearly as effective as this one.
The research into a malaria vaccine will not be stopping here though. Funding is continuous and researchers say they will in fact continue developing this and other vaccines until they are able to find a nearly completely successful vaccine. It will likely be years before another significant test result like this is released but researchers are still hopeful that some sort of vaccine will be available sometime in the foreseeable future. For now medical experts are simply happy to see that a significant amount of progress has been made on the path towards a malaria vaccine.